Disruption of the optic pathway during development affects vasoactive intestinal peptide mRNA expression
- PMID: 2488706
Disruption of the optic pathway during development affects vasoactive intestinal peptide mRNA expression
Abstract
Vasoactive intestinal polypeptide (VIP) is a regulatory peptide widely distributed in the central and peripheral nervous systems. To understand the activities of VIP it is necessary to study the mechanisms governing its production. The highest concentration of VIP-producing cells occurs in the suprachiasmatic nucleus (SCN) of the hypothalamus. Because the SCN is directly innervated by the optic nerve, we decided to investigate the effect of visual input on VIP gene expression. By means of Northern blot hybridization, we measured VIP mRNA levels in the hypothalami of 36-day-old normal rats and rats that had been enucleated at birth. The concentration of VIP mRNA in the hypothalami of enucleated rats was approximately double that in the hypothalami of normal rats. In contrast, the concentration of VIP mRNA in the cerebral cortex significantly decreased after enucleation. The concentrations of VIP mRNA were also measured by in situ hybridization to brain sections. The hypothalamic VIP mRNA was located mainly in the SCN. Enucleation resulted in an increase of VIP transcripts in the SCN. These results indicate that visual input may participate in the regulation of VIP production.
Similar articles
-
Regulation of VIP gene expression in general. Human lung cancer cells in particular.J Mol Neurosci. 1996 Summer;7(2):99-110. doi: 10.1007/BF02736790. J Mol Neurosci. 1996. PMID: 8873894 Review.
-
Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites.J Comp Neurol. 2004 Jul 12;475(1):19-35. doi: 10.1002/cne.20168. J Comp Neurol. 2004. PMID: 15176082
-
Ageing and the diurnal expression of mRNAs for vasoactive intestinal peptide and for the VPAC2 and PAC1 receptors in the suprachiasmatic nucleus of male rats.J Neuroendocrinol. 2004 Sep;16(9):758-66. doi: 10.1111/j.1365-2826.2004.01232.x. J Neuroendocrinol. 2004. PMID: 15344914
-
Daily and circadian expression of neuropeptides in the suprachiasmatic nuclei of nocturnal and diurnal rodents.Brain Res Mol Brain Res. 2004 May 19;124(2):143-51. doi: 10.1016/j.molbrainres.2004.01.010. Brain Res Mol Brain Res. 2004. PMID: 15135222
-
[Chemical neuro-anatomy of the thalamus: an example of the co-expression of 2 neuropeptides, cholecystokinin and intestinal vasoactive peptide].Schweiz Med Wochenschr. 1990 Aug 18;120(33):1180-5. Schweiz Med Wochenschr. 1990. PMID: 2204106 Review. French.
Cited by
-
Regulation of VIP gene expression in general. Human lung cancer cells in particular.J Mol Neurosci. 1996 Summer;7(2):99-110. doi: 10.1007/BF02736790. J Mol Neurosci. 1996. PMID: 8873894 Review.
-
VIP, from gene to behavior and back: summarizing my 25 years of research.J Mol Neurosci. 2008 Nov;36(1-3):115-24. doi: 10.1007/s12031-008-9105-3. Epub 2008 Jul 8. J Mol Neurosci. 2008. PMID: 18607776
-
Activity-dependent neurotrophic factor (ADNF). An extracellular neuroprotective chaperonin?J Mol Neurosci. 1996 Winter;7(4):235-44. doi: 10.1007/BF02737061. J Mol Neurosci. 1996. PMID: 8968945 Review.
-
VIP: molecular biology and neurobiological function.Mol Neurobiol. 1989 Winter;3(4):201-36. doi: 10.1007/BF02740606. Mol Neurobiol. 1989. PMID: 2698176 Review.
-
Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo.J Mol Neurosci. 2007;33(3):278-83. doi: 10.1007/s12031-007-9003-0. Epub 2007 Oct 2. J Mol Neurosci. 2007. PMID: 17952637